High Quality Avatrombopag CAS 570406-98-3 Powder Fast Shipping
570406-98-3
Pharmaceutical Grade
99.5%
Hangzhou
HyperChem
1kg/Bag
2025-05-16
Pharmaceuticals,Peptide,Cosmetics,Nutritional Supplements
-
Product Description
-
Seller Information
-
DescriptionECHEMI Editorial ReferenceAvatrombopag(AKR-501; AS1670542) is a novel orally-active thrombopoietin(TPO) receptor agonist with EC50 of 3.3 nM.EC50 value: 3.3 nM [1]Target: TPO receptor agonistin vitro: AKR-501 specifically targeted the TPO receptor and stimulated megakaryocytopoiesis throughout the development and maturation of megakaryocytes just as rhTPO did. AKR-501, however, was shown to be effective only in humans and chimpanzees with high species specificity [1]. AS1670542 has 50% effective concentration val
Avatrombopag (Doptelet), is an orally administered, small-molecule thrombopoietin receptor (c-Mpl) agonist which increases platelet number, but not platelet activation,. This decreases the need for blood transfusions. Patients with thrombocytopenia and chronic liver disease (leading to thrombocytopenia) often require platelet transfusions before surgical procedures to decrease the risk of bleeding. Thrombocytopenia (or decreased numbers of platelets) is a common complication in patients suffering from chronic liver disease, either as an immediate result of liver disease or a consequence of interferon-based antiviral therapy. Avatrombopag was approved by the FDA on May 21, 2018 for thrombocytopenia (low platelets) in adults with chronic liver disease who are scheduled to undergo a procedure. It is administered orally as avatrombopag maleate, its salt form. Doptelet (Avatrombopag) is the first orally administered treatment option for patients with chronic liver disease, allowing a large population of patients to avoid a platelet transfusion before a procedure by increasing platelet counts to the optimal level of greater or equal to 50,000 per microliter.|The thrombopoietin receptor agonists mimic the action of thrombopoietin on its receptor and stimulate the activation, proliferation and maturation of megakaryocytes, resulting in an increase in circulating platelet counts. Thrombopoietin itself acts in this manner, but when recombinant thrombopoietins were used clinically, they were found to cause rebound thrombocytopenia, probably due to induction of anti-thrombopoietin antibodies. For this reason, direct administration of thrombopoietin was abandoned as an approach to treating thrombocytopenia and other approaches to activating the thrombopoietin receptor were sought.|Avatrombopag is an orally available platelet thrombopoietin receptor (TPOR; MPL) agonist, with potential megakaryopoiesis stimulating activity. Upon administration, avatrombopag binds to and stimulates TPOR, which may lead to the proliferation and differentiation of megakaryocytes from bone marrow progenitor cells. This increases the production of platelets and may prevent chemotherapy-induced thrombocytopenia (CIT). TPOR is a cytokine receptor and member of the hematopoietin receptor superfamily.Basic Info-
Product Name:
Avatrombopag
Other Name:4-Piperidinecarboxylic acid,1-[3-chloro-5-[[[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]amino]carbonyl]-2-pyridinyl]-;1-[3-Chloro-5-[[[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]amino]carbonyl]-2-pyridinyl]-4-piperidinecarboxylic acid;1-[3-Chloro-5-[[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl]carbamoyl]-2-pyridyl]piperidine-4-carboxylic acid;1-(3-Chloro-5-[[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl]carbamoyl]pyridin-2-yl)piperidine-4-carboxylic acid;AKR 501;AS 1670542;E 5501;Avatrombopag;Doptelet
CAS No.:570406-98-3
Molecular Formula:C29H34Cl2N6O3S2
InChIKeys:InChIKey=OFZJKCQENFPZBH-UHFFFAOYSA-N
Molecular Weight:649.67
Exact Mass:649.65
EC Number:1312995-182-4
UNII:3H8GSZ4SQL
DSSTox ID:DTXSID30205667
NCI Thesaurus Code:C150559
ATC Code:B02BX|B - Blood and blood forming organs
Categories:
Characteristics-
PSA:
158
XLogP3:6.82
Density:1.4±0.1 g/cm3
Refractive Index:1.671
Water Solubility:H2O: Insoluble
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Pharmaceuticals,Peptide,Cosmetics,Nutritional Supplements
-
Location:
Rm. 803, Tower 4, LOFT49 Creative City Pioneer Zone, No.88 Jiru Rd. Gongshu Dist., Hangzhou, 310015 ZJ, China
-
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
10 days
-
Total Annual Revenue:
$5 million-$10 million
-
Total Employees:
11-50
-
Year of Establishment:
2013
Company Certificates-
Certification Report by Bureau Veritas
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product
More from this Seller
-
-
-
Erdafitinib CAS 1346242-81-6 JNJ-42756493 Balversa FGFR Tyrosine Kinase Inhibitor Anti-Cancer API 99% Purity
Pharmaceutical Grade / 99%
$5-6/MT FOB
-
-
-
-
High Quality Adenosine CAS 58-61-7 with best price and fast delivery
Pharmaceutical Grade / 99%
-
-
-
-
99% Assay Mupirocin calcium CAS 115074-43-6 White Powder USP Standard Fast Delivery
Pharmaceutical Grade / 99%
$1700-1800/KG FOB
-
-
-
-
Wholesale Odanacatib MK0822 Powder CAS603139-19-1 Anti-Osteoporosis API Intermediate For Clinical Trial Research
Pharmaceutical Grade / 99.9%
$400-500/G FOB
-
-
-
-
Hot Sale High Purity 98% Selank Peptide Raw Powder CAS 129954-34-3 ready stock and best price
Pharmaceutical Grade / 99%
-
-
-
-
Pharmaceutical Grade Vosoritide Acetate API | Achondroplasia Targeted Peptide | CAS 1480724-61-5
Pharmaceutical Grade / 99%
-